您当前的位置：
首页 >
文章列表页 >
Proteomics-based Investigation of Therapeutic Effect and Mechanism of Verbenalin on Lung Injury in Mice Infected with Human Coronavirus-229E
更新时间：2025-12-04

    • Proteomics-based Investigation of Therapeutic Effect and Mechanism of Verbenalin on Lung Injury in Mice Infected with Human Coronavirus-229E

      增强出版
    • “The latest research has found that verbascoside can effectively treat human coronavirus 229E infection, possibly by regulating the NLRP3 inflammasome pathway and mitochondrial autophagy.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 24, Pages: 69-78(2025)

    • DOI：10.13422/j.cnki.syfjx.20242436    

      CLC： R285;R242;R254

    • Received：18 October 2024，

      Revised：2024-12-24，

      Accepted：31 December 2024，

      Published Online：07 January 2025，

      Published：20 December 2025

    移动端阅览

  • SUN Qiyue,GUO Shanshan,GAO Shuangrong,et al.Proteomics-based Investigation of Therapeutic Effect and Mechanism of Verbenalin on Lung Injury in Mice Infected with Human Coronavirus-229E[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(24):69-78. DOI： 10.13422/j.cnki.syfjx.20242436.

  •  
  •  

0

Views

54

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Preliminary Proteomics-based Investigation of Inhibitory Effect and Mechanism of BD-77 by Nebulized Inhalation on Respiratory Viral Infections
Effect of Shufeng Jiedu Capsules on Improving Lung Inflammation in Mice Infected with Human Coronavirus 229E by Regulating TLR4/TRIF/TBK1 Signaling Pathway
Research on Regulatory Mechanism of Verbenalin on HCoV-229E-infected Macrophage Injury Based on Mitophagy
Mechanism of Huangqi Gegen Decoction in Treatment of Type 2 Diabetes Mellitus via Intestinal Mucosal Barrier

Related Author

ZHOU Lirun
LI Xing
HUANG Cigang
JIANG Kun
PENG Feiyan
BAO Lei
GENG Zihan
GUO Shanshan

Related Institution

Shanghai Institute of Materia Medica，Chinese Academy of Sciences
Medical Sciences Guizhou Bailing Enterprise Group Pharmaceutical Co.Ltd
Shanxi Key Laboratory of Innovative Drug for Treatment of Serious Diseases Basing on Chronic Inflammation，College of Traditional Chinese Medicine and Food Engineering， Shanxi University of Chinese Medicine
Natural History Museum of China
Beijing Key Laboratory of Chinese Materia Pharmacology，Institute of Basic Medical Sciences， Xiyuan Hospital，China Academy of Chinese Medical Sciences
0